| Inducible apoptosis as a safety switch for adoptive cell therapy A Di Stasi, SK Tey, G Dotti, Y Fujita, A Kennedy-Nasser, C Martinez, ... New England Journal of Medicine 365 (18), 1673-1683, 2011 | 1626 | 2011 |
| Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML AE Perl, G Martinelli, JE Cortes, A Neubauer, E Berman, S Paolini, ... New England Journal of Medicine 381 (18), 1728-1740, 2019 | 1070 | 2019 |
| T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model A Di Stasi, B De Angelis, CM Rooney, L Zhang, A Mahendravada, ... Blood, The Journal of the American Society of Hematology 113 (25), 6392-6402, 2009 | 588 | 2009 |
| Epstein Barr virus–specific cytotoxic T lymphocytes expressing the anti-CD30ζ artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease B Savoldo, CM Rooney, A Di Stasi, H Abken, A Hombach, AE Foster, ... Blood, The Journal of the American Society of Hematology 110 (7), 2620-2630, 2007 | 295 | 2007 |
| Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen–matched unrelated and … A Di Stasi, DR Milton, LM Poon, A Hamdi, G Rondon, J Chen, SR Pingali, ... Biology of Blood and Marrow Transplantation 20 (12), 1975-1981, 2014 | 255 | 2014 |
| Improving the safety of cell therapy products by suicide gene transfer BS Jones, LS Lamb, F Goldman, A Di Stasi Frontiers in pharmacology 5, 254, 2014 | 249 | 2014 |
| Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation X Zhou, G Dotti, RA Krance, CA Martinez, S Naik, RT Kamble, AG Durett, ... Blood, The Journal of the American Society of Hematology 125 (26), 4103-4113, 2015 | 234 | 2015 |
| Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene X Zhou, A Di Stasi, SK Tey, RA Krance, C Martinez, KS Leung, AG Durett, ... Blood, The Journal of the American Society of Hematology 123 (25), 3895-3905, 2014 | 186 | 2014 |
| Review of the results of WT1 peptide vaccination strategies for myelodysplastic syndromes and acute myeloid leukemia from nine different studies A Di Stasi, AM Jimenez, K Minagawa, M Al-Obaidi, K Rezvani Frontiers in immunology 6, 36, 2015 | 125 | 2015 |
| In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia K Minagawa, MO Jamil, M Al-Obaidi, L Pereboeva, D Salzman, HP Erba, ... PLoS One 11 (12), e0166891, 2016 | 94 | 2016 |
| Seatbelts in CAR therapy: how safe are CARS? K Minagawa, X Zhou, S Mineishi, A Di Stasi Pharmaceuticals 8 (2), 230-249, 2015 | 57 | 2015 |
| Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation A Hamdi, R Mawad, R Bassett, A di Stasi, R Ferro, A Afrough, R Ram, ... Biology of Blood and Marrow Transplantation 20 (11), 1767-1771, 2014 | 56 | 2014 |
| Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation? P Kongtim, A Di Stasi, G Rondon, J Chen, K Adekola, U Popat, B Oran, ... Biology of Blood and Marrow Transplantation 21 (4), 713-719, 2015 | 54 | 2015 |
| Gilteritinib significantly prolongs overall survival in patients with FLT3-mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML): Results from the Phase III … AE Perl, G Martinelli, JE Cortes, A Neubauer, E Berman, S Paolini, ... Cancer Research 79 (13), 2019 | 53 | 2019 |
| Hematopoietic cell transplantation, version 2.2020, NCCN clinical practice guidelines in oncology A Saad, M de Lima, S Anand, VR Bhatt, R Bookout, G Chen, D Couriel, ... Journal of the National Comprehensive Cancer Network 18 (5), 599-634, 2020 | 48 | 2020 |
| Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation LM Poon, A Di Stasi, U Popat, RE Champlin, SO Ciurea American journal of blood research 3 (3), 260, 2013 | 45 | 2013 |
| Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin … S Viviani, M Di Nicola, V Bonfante, A Di Stasi, C Carlo-Stella, P Matteucci, ... Leukemia & lymphoma 51 (7), 1251-1259, 2010 | 43 | 2010 |
| Generation of suicide gene-modified chimeric antigen receptor-redirected T-cells for cancer immunotherapy K Minagawa, M Al-Obaidi, A Di Stasi Suicide Gene Therapy: Methods and Protocols, 57-73, 2019 | 37 | 2019 |
| Regulated apoptosis of genetically modified hematopoietic stem and progenitor cells via an inducible caspase-9 suicide gene in rhesus macaques CN Barese, TC Felizardo, SE Sellers, K Keyvanfar, A Di Stasi, ... Stem Cells 33 (1), 91-100, 2015 | 36 | 2015 |
| iCaspase 9 suicide gene system X Zhou, A Di Stasi, MK Brenner Gene Therapy of Solid Cancers: Methods and Protocols, 87-105, 2015 | 25 | 2015 |
